Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723].
[en] The authors regret that there is an error in the abstract. In the sentence “Among 527 patients screened from 14 centers in France, Belgium and Portugal, a final cohort of 269 patients ≤65 years old with PTCL-not otherwise specified (NOS) (N = 78, 29%), angioimmunoblastic T-cell lymphoma (AITL) (N = 123, 46%) and anaplastic lymphoma kinase-positive anaplastic large cell lymphoma (ALK-ALCL) (N = 68, 25%) with partial (N = 52, 19%) or complete responses (N = 217, 81%) after induction was identified and information about treatment allocation was carefully collected before therapy initiation from medical records”, the term “anaplastic lymphoma kinase-positive anaplastic large cell lymphoma” should read “anaplastic lymphoma kinase-negative anaplastic large cell lymphoma”. The authors would like to apologise for any inconvenience caused.
Disciplines :
Hematology
Author, co-author :
Fossard, G; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France, Claude Bernard Lyon 1 University, Lyon, France, Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France
Broussais, F; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
Coelho, I; Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal
Bailly, S; Hematology and Cell Therapy Department, Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand, France, Clermont Auvergne University, Clermont-Ferrand, France
Nicolas-Virelizier, E; Hematology Department, Centre Leon Berard, Lyon, France
Toussaint, E; Hematology Department, CHU de Strasbourg, Strasbourg, France
Lancesseur, C; Hematology Institute, CHU de Caen, Caen, France
Le Bras, F; Hematology Department, CHU Henri Mondor, Creteil, France
WILLEMS, Evelyne
Tchernonog, E; Hematology Department, CHU de Montpellier, Montpellier, France
Chalopin, T; Hematology Department, CHU de Tours, Tours, France
Gressin, R; Hematology Department, CHU de Grenoble, Grenoble, France
Chauchet, A; Hematology Department, CHU de Besançon, Besançon, France
Gyan, E; Hematology Department, CHU de Tours, Tours, France
Cartron, G; Hematology Department, CHU de Montpellier, Montpellier, France
Bonnet, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Haioun, C; Hematology Department, CHU Henri Mondor, Creteil, France
Damaj, G; Hematology Institute, CHU de Caen, Caen, France
Gaulard, P; Hematology Department, CHU Henri Mondor, Creteil, France
Fornecker, L; Hematology Department, CHU de Strasbourg, Strasbourg, France
Ghesquières, H; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
Tournilhac, O; Hematology and Cell Therapy Department, Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand, France, Clermont Auvergne University, Clermont-Ferrand, France
Gomesda Silva, M; Hematology Department, Portuguese Institute of Oncology, Lisbon, Portugal
Bouabdallah, R; Hematology Department, Institut Paoli Calmette, Marseille, France
Salles, G; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France, Claude Bernard Lyon 1 University, Lyon, France, Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France
Bachy, E; Hematology Department, CHU Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France, Claude Bernard Lyon 1 University, Lyon, France, Cancer Center of Lyon (CRCL), INSERM U1052 - CNRS UMR5286, Lyon, France. Electronic address: emmanuel.bachy@chu-lyon.fr
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723].
Alternative titles :
[en] Corrigendum to “Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers”: (Annals of Oncology (2018) 29(3) (715–723), (S0923753419354997))
